The topic content is divided into the information types below
Ambitions for change: Improving healthcare in care homes
This document describes the care home sector across the UK as it currently stands, how health and wellbeing has traditionally been supported in care homes and sets out what good healthcare provision in a care home environment should look like.
Silver Book II: Geriatric syndromes
This chapter of the Silver Book II covers the presentation of common geriatric conditions in an urgent care context.
The Patients Association Care Home Charter
The Patients Association's Care Home Charter was launched in 2019 to improve medication practices for people living in care homes across the UK.
COVID-19: Treatment for older people in the community
This page brings together guidance and practical advice for the management of older adults with COVID-19 in the community, including drug treatment and examples of standard operating procedures (SOPs).
Medicine optimisation: Recommended reading and resources
This list of recommended resources and further information on medicines optimisation in older people has been curated by the BGS Medicine Optimisation Special Interest Group (SIG).
End of Life Care in Frailty: Medicines management
This section of the BGS guidance on end of life care in older people examines the issue of polypharmacy at the end of life.
COVID-19 and medicines advice for older people
Older people are particularly at risk from complications as a result of COVID-19 and many are likely to already be taking medication for other conditions.
Age and Ageing collection: Treatments in Dementia
This collection of 15 papers provides an update on interventions in dementia in the past 15 years.
Effective record keeping and ordering of medicines - for Care Home Managers
SCIE has published a guide and created an interactive web resource for home care managers providing medicines support.
Benzodiazepines and falls risk
Falls are a frequent and frightening issue for patients and staff, and they have physical and psychological consequences for individuals and society. They are costly in human and financial terms (National Institute for Health and Clinical ExceIlence 2004).
Vaccination programmes in Older People
Infectious diseases account for a significant proportion of hospital admissions and deaths in the elderly. Unfortunately the immunological response to vaccines in older individuals is less than that in younger adults. We assess best practice in immunisation programmes among older people.